Expression of SGCE in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

SGCE is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 36.83

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

55.9

Number of samples

141

Samples

Sample	Description	TPM
TCGA-32-2615-01A	0 years, male, white, stage:'--, dead, 485 days	982.6
TCGA-06-5413-01A	0 years, male, white, stage:'--, alive, 268 days	131.1
TCGA-06-2569-01A	0 years, female, black or african american, stage:'--, alive, 13 days	125.1
TCGA-14-1829-01A	0 years, male, black or african american, stage:'--, alive, 218 days	121.2
TCGA-06-5412-01A	0 years, female, white, stage:'--, dead, 138 days	112.3
TCGA-28-5218-01A	0 years, male, white, stage:'--, dead, 157 days	110.8
TCGA-06-2562-01A	0 years, male, white, stage:'--, dead, 382 days	110.5
TCGA-28-2509-01A	0 years, female, white, stage:'--, alive, 145 days	107.7
TCGA-06-5858-01A	0 years, female, white, stage:'--, alive, 187 days	107.4
TCGA-08-0386-01A	0 years, male, white, stage:'--, dead, 548 days	98.5
TCGA-27-1831-01A	0 years, male, white, stage:'--, dead, 505 days	97.1
TCGA-06-0184-01A	0 years, male, white, stage:'--, dead, 2126 days	94.9
TCGA-19-2619-01A	0 years, female, black or african american, stage:'--, alive, 294 days	91.9
TCGA-28-2513-01A	0 years, female, white, stage:'--, alive, 222 days	86.3
TCGA-76-4929-01A	0 years, female, white, stage:'--, dead, 111 days	82.2
TCGA-12-5295-01A	0 years, female, white, stage:'--, dead, 454 days	81.6
TCGA-26-5139-01A	0 years, female, white, stage:'--, alive, 48 days	78.8
TCGA-06-0750-01A	0 years, male, white, stage:'--, dead, 28 days	78.5
TCGA-28-5204-01A	0 years, male, white, stage:'--, dead, 454 days	78.1
TCGA-06-5414-01A	0 years, male, white, stage:'--, alive, 273 days	77.5
TCGA-14-0787-01A	0 years, male, asian, stage:'--, dead, 68 days	76.8
TCGA-06-0138-01A	0 years, male, white, stage:'--, dead, 737 days	74.5
TCGA-06-5416-01A	0 years, female, white, stage:'--, alive, 204 days	73.4
TCGA-12-5299-01A	0 years, female, white, stage:'--, dead, 98 days	72.6
TCGA-12-0821-01A	0 years, male, white, stage:'--, dead, 323 days	71.3
TCGA-12-3650-01A	0 years, male, white, stage:'--, dead, 333 days	71.1
TCGA-14-2554-01A	0 years, female, white, stage:'--, dead, 532 days	71.1
TCGA-06-0646-01A	0 years, male, white, stage:'--, dead, 175 days	70.5
TCGA-26-5132-01A	0 years, male, white, stage:'--, alive, 286 days	70.1
TCGA-02-0055-01A	0 years, female, white, stage:'--, dead, 76 days	69.8
TCGA-14-0817-01A	0 years, female, white, stage:'--, dead, 164 days	69.4
TCGA-19-5960-01A	0 years, male, white, stage:'--, dead, 455 days	69.4
TCGA-06-5856-01A	0 years, male, white, stage:'--, dead, 114 days	69.4
TCGA-26-5133-01A	0 years, male, white, stage:'--, alive, 452 days	69.3
TCGA-12-0616-01A	0 years, female, white, stage:'--, dead, 448 days	68.1
TCGA-76-4927-01A	0 years, male, white, stage:'--, dead, 535 days	66.9
TCGA-06-0882-01A	0 years, male, white, stage:'--, dead, 632 days	66.1
TCGA-41-4097-01A	0 years, female, white, stage:'--, dead, 6 days	65.7
TCGA-06-0744-01A	0 years, male, white, stage:'--, dead, 1426 days	63.9
TCGA-27-1830-01A	0 years, male, white, stage:'--, dead, 154 days	63.6
TCGA-41-3915-01A	0 years, male, white, stage:'--, dead, 360 days	62.4
TCGA-19-4065-01A	0 years, male, white, stage:'--, alive, 214 days	62.4
TCGA-06-0156-01A	0 years, male, white, stage:'--, dead, 178 days	61.8
TCGA-32-2634-01A	0 years, male, white, stage:'--, alive, 693 days	61.6
TCGA-27-1834-01A	0 years, male, white, stage:'--, dead, 1233 days	61.6
TCGA-06-5408-01A	0 years, female, white, stage:'--, dead, 357 days	60.3
TCGA-06-5411-01A	0 years, male, white, stage:'--, dead, 254 days	59.9
TCGA-14-0789-01A	0 years, male, white, stage:'--, dead, 342 days	58.8
TCGA-02-0047-01A	0 years, male, white, stage:'--, dead, 448 days	58.7
TCGA-06-0157-01A	0 years, female, white, stage:'--, dead, 97 days	58.2
TCGA-06-0686-01A	0 years, male, white, stage:'--, dead, 432 days	56.9
TCGA-28-5207-01A	0 years, male, white, stage:'--, dead, 343 days	56.9
TCGA-27-1832-01A	0 years, female, white, stage:'--, dead, 300 days	56.7
TCGA-32-1980-01A	0 years, male, white, stage:'--, dead, 36 days	55.9
TCGA-06-0190-01A	0 years, male, white, stage:'--, dead, 317 days	55.6
TCGA-28-5215-01A	0 years, female, white, stage:'--, dead, 335 days	55.4
TCGA-27-2519-01A	0 years, male, white, stage:'--, dead, 550 days	54.6
TCGA-28-5208-01A	0 years, male, white, stage:'--, dead, 544 days	54.4
TCGA-14-1034-01A	0 years, female, stage:'--, dead, 485 days	54.0
TCGA-06-1804-01A	0 years, female, white, stage:'--, dead, 414 days	53.5
TCGA-06-0211-01A	0 years, male, white, stage:'--, dead, 360 days	53.3
TCGA-06-0125-01A	0 years, female, white, stage:'--, dead, 1448 days	52.5
TCGA-06-2558-01A	0 years, female, white, stage:'--, dead, 380 days	51.9
TCGA-02-2485-01A	0 years, male, black or african american, stage:'--, alive, 470 days	51.7
TCGA-28-5216-01A	0 years, male, white, stage:'--, alive, 415 days	50.6
TCGA-06-0238-01A	0 years, male, white, stage:'--, dead, 405 days	48.9
TCGA-28-2514-01A	0 years, male, asian, stage:'--, alive, 160 days	48.8
TCGA-06-0158-01A	0 years, male, white, stage:'--, dead, 329 days	48.6
TCGA-06-2564-01A	0 years, male, white, stage:'--, alive, 181 days	48.5
TCGA-26-5135-01A	0 years, female, white, stage:'--, dead, 270 days	48.3
TCGA-06-5859-01A	0 years, male, white, stage:'--, alive, 139 days	47.7
TCGA-06-0743-01A	0 years, male, white, stage:'--, dead, 803 days	47.6
TCGA-32-2638-01A	0 years, male, white, stage:'--, dead, 766 days	47.4
TCGA-12-3653-01A	0 years, female, white, stage:'--, dead, 442 days	47.3
TCGA-06-2567-01A	0 years, male, white, stage:'--, dead, 133 days	46.7
TCGA-06-0745-01A	0 years, male, white, stage:'--, dead, 239 days	46.5
TCGA-06-0644-01A	0 years, male, black or african american, stage:'--, dead, 384 days	46.3
TCGA-15-0742-01A	0 years, male, white, stage:'--, dead, 419 days	45.4
TCGA-32-1970-01A	0 years, male, white, stage:'--, dead, 468 days	43.8
TCGA-02-2483-01A	0 years, male, asian, stage:'--, alive, 466 days	43.5
TCGA-06-0210-01A	0 years, female, white, stage:'--, dead, 225 days	43.4
TCGA-06-5417-01A	0 years, female, white, stage:'--, alive, 155 days	43.3
TCGA-27-2526-01A	0 years, female, white, stage:'--, dead, 87 days	42.2
TCGA-06-5410-01A	0 years, female, white, stage:'--, dead, 108 days	39.5
TCGA-06-2559-01A	0 years, male, white, stage:'--, dead, 150 days	39.3
TCGA-19-2629-01A	0 years, male, white, stage:'--, dead, 737 days	39.2
TCGA-19-2624-01A	0 years, male, white, stage:'--, dead, 5 days	37.9
TCGA-02-2486-01A	0 years, male, white, stage:'--, dead, 618 days	37.1
TCGA-06-0139-01A	0 years, male, white, stage:'--, dead, 362 days	36.9
TCGA-06-0129-01A	0 years, male, asian, stage:'--, dead, 1024 days	36.8
TCGA-12-3652-01A	0 years, male, white, stage:'--, dead, 1062 days	36.6
TCGA-15-1444-01A	0 years, male, white, stage:'--, dead, 1537 days	36.5
TCGA-16-0846-01A	0 years, male, white, stage:'--, dead, 119 days	36.3
TCGA-06-0219-01A	0 years, male, white, stage:'--, dead, 22 days	36.3
TCGA-27-2523-01A	0 years, male, white, stage:'--, dead, 489 days	36.2
TCGA-06-0878-01A	0 years, male, white, stage:'--, alive, 218 days	35.6
TCGA-12-0619-01A	0 years, male, white, stage:'--, dead, 1062 days	35.0
TCGA-06-2570-01A	0 years, female, white, stage:'--, alive, 958 days	34.9
TCGA-41-5651-01A	0 years, female, black or african american, stage:'--, dead, 460 days	32.9
TCGA-06-0174-01A	0 years, male, white, stage:'--, dead, 98 days	32.9
TCGA-06-0178-01A	0 years, male, white, stage:'--, dead, 2681 days	31.1
TCGA-19-2620-01A	0 years, male, white, stage:'--, dead, 148 days	28.8
TCGA-27-2521-01A	0 years, male, white, stage:'--, dead, 510 days	28.7
TCGA-06-2565-01A	0 years, male, asian, stage:'--, dead, 506 days	28.4
TCGA-14-1825-01A	0 years, male, white, stage:'--, dead, 232 days	28.3
TCGA-06-0168-01A	0 years, female, white, stage:'--, dead, 598 days	28.2
TCGA-12-0618-01A	0 years, male, white, stage:'--, dead, 395 days	28.1
TCGA-06-2561-01A	0 years, female, white, stage:'--, dead, 537 days	28.1
TCGA-06-2557-01A	0 years, male, black or african american, stage:'--, dead, 33 days	27.9
TCGA-14-1823-01A	0 years, female, white, stage:'--, dead, 543 days	27.0
TCGA-06-0141-01A	0 years, male, white, stage:'--, dead, 313 days	26.5
TCGA-19-1390-01A	0 years, female, white, stage:'--, dead, 772 days	25.8
TCGA-27-1837-01A	0 years, male, white, stage:'--, dead, 427 days	25.3
TCGA-41-2571-01A	0 years, male, white, stage:'--, dead, 26 days	23.4
TCGA-32-5222-01A	0 years, male, white, stage:'--, dead, 585 days	23.3
TCGA-27-1835-01A	0 years, female, white, stage:'--, dead, 648 days	23.0
TCGA-76-4932-01A	0 years, female, white, stage:'--, dead, 1458 days	22.8
TCGA-06-0130-01A	0 years, male, white, stage:'--, dead, 394 days	21.5
TCGA-06-2563-01A	0 years, female, white, stage:'--, alive, 932 days	21.1
TCGA-26-1442-01A	0 years, male, white, stage:'--, alive, 953 days	20.5
TCGA-06-0645-01A	0 years, female, white, stage:'--, dead, 175 days	19.9
TCGA-06-5418-01A	0 years, female, white, stage:'--, dead, 83 days	17.2
TCGA-19-2625-01A	0 years, female, white, stage:'--, dead, 124 days	16.8
TCGA-06-0132-01A	0 years, male, white, stage:'--, dead, 771 days	16.7
TCGA-27-2524-01A	0 years, male, white, stage:'--, dead, 231 days	16.7
TCGA-06-0187-01A	0 years, male, white, stage:'--, dead, 828 days	16.6
TCGA-14-0871-01A	0 years, female, white, stage:'--, dead, 880 days	15.4
TCGA-41-2572-01A	0 years, male, white, stage:'--, dead, 406 days	15.0
TCGA-32-1982-01A	0 years, female, white, stage:'--, dead, 142 days	14.9
TCGA-06-0749-01A	0 years, male, black or african american, stage:'--, dead, 82 days	12.1
TCGA-76-4931-01A	0 years, female, white, stage:'--, dead, 279 days	11.9
TCGA-28-1753-01A	0 years, male, white, stage:'--, alive, 37 days	11.1
TCGA-32-2632-01A	0 years, male, white, stage:'--, dead, 269 days	10.9
TCGA-32-2616-01A	0 years, female, white, stage:'--, dead, 224 days	9.8
TCGA-32-4213-01A	0 years, female, white, stage:'--, alive, 604 days	9.5
TCGA-26-5134-01A	0 years, male, white, stage:'--, alive, 167 days	8.8
TCGA-27-2528-01A	0 years, male, white, stage:'--, dead, 480 days	7.9
TCGA-28-5209-01A	0 years, female, white, stage:'--, alive, 442 days	5.1
TCGA-28-5220-01A	0 years, male, white, stage:'--, dead, 388 days	5.0
TCGA-76-4925-01A	0 years, male, white, stage:'--, dead, 146 days	3.6
TCGA-06-0747-01A	0 years, male, white, stage:'--, dead, 82 days	2.9
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

SGCE is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 15.58

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

22.0

Number of samples

Samples

Sample	Description	TPM
AK123	N, NA, stage:NA, dead, 180 days	51.6
AK139	N, NA, stage:NA, dead, 270 days	50.0
AK071	N, NA, stage:NA, dead, 540 days	45.4
AK173	N, NA, stage:NA, dead, 180 days	38.3
AK156	N, NA, stage:NA, dead, 330 days	36.4
AK218	N, NA, stage:NA, dead, 180 days	36.2
AK100	N, NA, stage:NA, alive, 960 days	36.2
AK142	N, NA, stage:NA, alive, 90 days	35.8
AK165	N, NA, stage:NA, alive, 360 days	34.8
AK213	N, NA, stage:NA, alive, 2010 days	34.8
AK074	N, NA, stage:NA, alive, 300 days	33.8
AK178	N, NA, stage:NA, dead, 240 days	31.9
AK053	N, NA, stage:NA, dead, 300 days	30.9
AK055	N, NA, stage:NA, dead, 240 days	30.2
AK079	N, NA, stage:NA, dead, 210 days	29.3
AK003	N, NA, stage:NA, dead, 600 days	26.3
AK236	N, NA, stage:NA, dead, 360 days	26.2
AK185	N, NA, stage:NA, alive, 330 days	25.8
AK051	N, NA, stage:NA, dead, 360 days	25.0
AK149	N, NA, stage:NA, dead, 420 days	24.3
AK227	N, NA, stage:NA, alive, 300 days	24.2
AK153	N, NA, stage:NA, dead, 240 days	23.9
AK183	N, NA, stage:NA, alive, 360 days	23.5
AK005	N, NA, stage:NA, dead, 240 days	23.4
AK076	N, NA, stage:NA, alive, 660 days	23.0
AK124	N, NA, stage:NA, alive, 1920 days	23.0
AK199	N, NA, stage:NA, alive, 1860 days	22.9
AK205	N, NA, stage:NA, dead, 120 days	22.2
AK195	N, NA, stage:NA, dead, 390 days	21.7
AK091	N, NA, stage:NA, dead, 210 days	21.7
AK231	N, NA, stage:NA, dead, 240 days	21.5
AK134	N, NA, stage:NA, dead, 360 days	21.1
AK167	N, NA, stage:NA, dead, 180 days	20.5
AK188	N, NA, stage:NA, alive, 420 days	20.5
AK158	N, NA, stage:NA, dead, 360 days	20.1
AK002	N, NA, stage:NA, dead, 570 days	17.7
AK049	N, NA, stage:NA, dead, 180 days	17.7
AK041	N, NA, stage:NA, alive, 810 days	17.3
AK030	N, NA, stage:NA, dead, 120 days	16.6
AK216	N, NA, stage:NA, dead, 360 days	15.8
AK117	N, NA, stage:NA, dead, 210 days	15.6
AK068	N, NA, stage:NA, alive, 360 days	15.6
AK102	N, NA, stage:NA, alive, 1740 days	15.4
AK133	N, NA, stage:NA, dead, 360 days	14.6
AK015	N, NA, stage:NA, alive, 720 days	13.9
AK085	N, NA, stage:NA, alive, 660 days	12.9
AK072	N, NA, stage:NA, dead, 150 days	12.6
AK035	N, NA, stage:NA, dead, 210 days	12.4
AK103	N, NA, stage:NA, alive, 1320 days	10.1
AK081	N, NA, stage:NA, dead, 180 days	9.6
AK043	N, NA, stage:NA, alive, 660 days	8.9
AK066	N, NA, stage:NA, alive, 960 days	7.1
AK006	N, NA, stage:NA, dead, 360 days	5.7
AK226	N, NA, stage:NA, dead, 360 days	5.2
AK088	N, NA, stage:NA, dead, 360 days	4.9
AK089	N, NA, stage:NA, dead, 330 days	4.5
AK098	N, NA, stage:NA, dead, 660 days	3.6
AK099	N, NA, stage:NA, dead, 420 days	3.4
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0190240004	Tumor	1.4
CPT0218670003	Tumor	1.1
CPT0205890003	Tumor	1.1
CPT0204420003	Normal	1.0
CPT0186100003	Tumor	0.9
CPT0168080003	Tumor	0.8
CPT0125510003	Tumor	0.8
CPT0204330003	Normal	0.7
CPT0204360003	Normal	0.7
CPT0204390003	Normal	0.7
CPT0167860004	Tumor	0.7
CPT0225760003	Tumor	0.7
CPT0093450003	Tumor	0.7
CPT0196850003	Tumor	0.6
CPT0204410003	Normal	0.6
CPT0209440003	Tumor	0.6
CPT0204380003	Normal	0.6
CPT0168270003	Tumor	0.6
CPT0208980003	Tumor	0.6
CPT0204350003	Normal	0.6
CPT0204370003	Normal	0.6
CPT0189570004	Tumor	0.5
CPT0104220003	Tumor	0.5
CPT0162140003	Tumor	0.5
CPT0216920008	Tumor	0.5
CPT0087730003	Tumor	0.5
CPT0217430008	Tumor	0.5
CPT0204340003	Normal	0.5
CPT0224390004	Tumor	0.4
CPT0167640003	Tumor	0.4
CPT0201710003	Tumor	0.4
CPT0168590003	Tumor	0.4
CPT0064650003	Tumor	0.4
CPT0093510003	Tumor	0.3
CPT0206330003	Tumor	0.3
CPT0171580008	Tumor	0.3
CPT0218960004	Tumor	0.3
CPT0199770003	Tumor	0.3
CPT0204400003	Normal	0.3
CPT0087680003	Tumor	0.3
CPT0205670004	Tumor	0.2
CPT0071100003	Tumor	0.2
CPT0168480003	Tumor	0.2
CPT0168830003	Tumor	0.2
CPT0093590003	Tumor	0.2
CPT0161730003	Tumor	0.2
CPT0182580003	Tumor	0.2
CPT0189650004	Tumor	0.2
CPT0127420003	Tumor	0.2
CPT0217880003	Tumor	0.2
CPT0206000004	Tumor	0.1
CPT0175060003	Tumor	0.1
CPT0079790003	Tumor	0.1
CPT0206110003	Tumor	0.1
CPT0218770003	Tumor	0.0
CPT0168380003	Tumor	0.0
CPT0224600003	Tumor	0.0
CPT0089150003	Tumor	0.0
CPT0190360004	Tumor	0.0
CPT0182500003	Tumor	0.0
CPT0219080004	Tumor	0.0
CPT0228220003	Tumor	0.0
CPT0218330004	Tumor	0.0
CPT0224330003	Tumor	0.0
CPT0206450003	Tumor	0.0
CPT0217100003	Tumor	-0.1
CPT0104330003	Tumor	-0.1
CPT0217190003	Tumor	-0.1
CPT0189250003	Tumor	-0.1
CPT0168720003	Tumor	-0.1
CPT0207030003	Tumor	-0.1
CPT0205450004	Tumor	-0.1
CPT0189850004	Tumor	-0.1
CPT0206560003	Tumor	-0.1
CPT0218830004	Tumor	-0.1
CPT0167970003	Tumor	-0.2
CPT0189750004	Tumor	-0.2
CPT0224540004	Tumor	-0.2
CPT0167750004	Tumor	-0.2
CPT0217000004	Tumor	-0.2
CPT0206670004	Tumor	-0.2
CPT0093360003	Tumor	-0.2
CPT0087570003	Tumor	-0.3
CPT0162020003	Tumor	-0.3
CPT0218690004	Tumor	-0.3
CPT0092440003	Tumor	-0.3
CPT0125570003	Tumor	-0.3
CPT0217060003	Tumor	-0.3
CPT0205570003	Tumor	-0.3
CPT0206780003	Tumor	-0.4
CPT0189460003	Tumor	-0.4
CPT0125220003	Tumor	-0.4
CPT0206880003	Tumor	-0.4
CPT0207090003	Tumor	-0.4
CPT0221180003	Tumor	-0.4
CPT0064890003	Tumor	-0.5
CPT0225730003	Tumor	-0.5
CPT0123530003	Tumor	-0.5
CPT0093550003	Tumor	-0.5
CPT0217710008	Tumor	-0.6
CPT0206230003	Tumor	-0.8
CPT0127480003	Tumor	-0.8
CPT0182550003	Tumor	-0.8
CPT0087950003	Tumor	-0.8
CPT0002410011	Tumor	-0.8
CPT0167530003	Tumor	-0.9
CPT0205780003	Tumor	-1.1
CPT0218890004	Tumor	-1.3
CPT0078580003	Tumor	-1.3
CPT0162100003	Tumor	-1.4
Show allShow less

GLIOMA - Protein expressionⁱ

Pending cancer tissue analysis